Theravance Biopharma Inc (TBPH)
Depreciation & Amortization
$1.44M
Quarterly · Period ending: · USD
TBPH Depreciation & Amortization
Latest reported$1.44Mperiod ending
Latest reported$1.44Mperiod ending
TBPH Quarterly Depreciation & Amortization ($778.00K → $1.44M)
Quarterly Depreciation & Amortization
High-resolution chart · PNG
TBPH depreciation & amortization history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 1,443,000 | |
| 835,000 | |
| 1,506,000 | |
| 636,000 | |
| 927,000 | |
| 1,052,000 | |
| 695,000 | |
| 762,000 | |
| 979,000 | |
| 1,179,000 | |
| 1,417,000 | |
| 1,339,000 | |
| 924,000 | |
| 978,000 | |
| 2,025,000 | |
| 1,767,000 | |
| 1,909,000 | |
| 1,323,000 | |
| 2,390,000 | |
| 2,609,000 | |
| 2,416,000 | |
| 2,293,000 | |
| 1,131,000 | |
| 1,984,000 | |
| 2,255,000 | |
| 2,345,000 | |
| 1,108,000 | |
| 1,919,000 | |
| 1,514,000 | |
| 1,673,000 | |
| 858,000 | |
| 618,000 | |
| 790,000 | |
| 900,000 | |
| 1,018,000 | |
| 950,000 | |
| 976,000 | |
| 1,083,000 | |
| 1,175,000 | |
| 791,000 | |
| 454,000 | |
| 699,000 | |
| 697,000 | |
| 1,111,000 | |
| 595,000 | |
| 586,000 | |
| 169,000 | |
| 1,075,000 | |
| 686,000 | |
| 732,000 | |
| 694,000 | |
| 557,000 | |
| 699,000 | |
| 703,000 | |
| 742,000 | |
| 778,000 |